In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Keros Therapeutics Inc’s stock clocked out at $11.93, up 2.23% from its previous closing price of $11.67. In other words, the price has increased by $2.23 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
To gain a deeper understanding of KROS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.45 and its Current Ratio is at 21.45. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On January 17, 2025, Wedbush Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $15.
Oppenheimer reiterated its Outperform rating for the stock on December 16, 2024, while the target price for the stock was revised from $102 to $63.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 13 ’24 when GORDON CARL L sold 250,000 shares for $44.01 per share. The transaction valued at 11,002,500 led to the insider holds 119,522 shares of the business.
ORBIMED ADVISORS LLC sold 250,000 shares of KROS for $11,002,500 on Aug 13 ’24. The Director now owns 119,522 shares after completing the transaction at $44.01 per share. On Aug 13 ’24, another insider, OrbiMed Genesis Master Fund, L, who serves as the Shareholder of the company, bought 29,400 shares for $44.84 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 136.31 while its Price-to-Book (P/B) ratio in mrq is 0.85.
Stock Price History:
Over the past 52 weeks, KROS has reached a high of $72.37, while it has fallen to a 52-week low of $9.77. The 50-Day Moving Average of the stock is -3.92%, while the 200-Day Moving Average is calculated to be -71.54%.
Shares Statistics:
A total of 40.55M shares are outstanding, with a floating share count of 32.87M. Insiders hold about 18.96% of the company’s shares, while institutions hold 77.94% stake in the company.
